Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma

Kudo, M

Kudo, M (通讯作者)，Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Liver Canc, Higashiosaka, Japan.

LIVER CANCER, 2022; 11 (2): 87

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索